Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept in Giant Cell Arteritis (ABAGART)
NCT04474847Phase 3Recruiting
- Sponsor
- University of Pennsylvania
- Start
- Mar 2021
- Primary completion
- Dec 2029
- Modality
- Fc-Fusion Proteins
- Countries
- 3
01
Overview
A Phase 3 trial of abatacept in giant cell arteritis (GCA), sponsored by University of Pennsylvania. Started Mar 2021; status: recruiting.
02
Drugs
abatacept
03
Conditions
giant cell arteritis (GCA)
Beyond the preview
Go deeper on NCT04474847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04474847.